Page last updated: 2024-10-27

fluorouracil and Hyphema

fluorouracil has been researched along with Hyphema in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Hyphema: Bleeding in the anterior chamber of the eye.

Research Excerpts

ExcerptRelevanceReference
"Others were encapsulated bleb 7."1.35Post-operative complication of trabeculectomy in Ibadan, Nigeria: outcome of 1-year follow-up. ( Ashaye, AO; Komolafe, OO, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashaye, AO1
Komolafe, OO1

Other Studies

1 other study available for fluorouracil and Hyphema

ArticleYear
Post-operative complication of trabeculectomy in Ibadan, Nigeria: outcome of 1-year follow-up.
    Eye (London, England), 2009, Volume: 23, Issue:2

    Topics: Adult; Aged; Anterior Chamber; Antimetabolites; Blister; Epidemiologic Methods; Female; Fluorouracil

2009